These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15674341)

  • 1. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization.
    Hanson S; Kim E; Deppert W
    Oncogene; 2005 Feb; 24(9):1641-7. PubMed ID: 15674341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.
    Cun Y; Dai N; Li M; Xiong C; Zhang Q; Sui J; Qian C; Wang D
    Oncol Rep; 2014 Feb; 31(2):901-9. PubMed ID: 24297337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo.
    Gaiddon C; Moorthy NC; Prives C
    EMBO J; 1999 Oct; 18(20):5609-21. PubMed ID: 10523305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
    Seemann S; Hainaut P
    Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
    Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
    Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
    Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
    J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
    Fishel ML; Kelley MR
    Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium compounds regulate p53 by common and distinctive mechanisms.
    Smith ML; Lancia JK; Mercer TI; Ip C
    Anticancer Res; 2004; 24(3a):1401-8. PubMed ID: 15274301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex.
    Fischer JL; Lancia JK; Mathur A; Smith ML
    Anticancer Res; 2006; 26(2A):899-904. PubMed ID: 16619485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.
    Song YJ; Lee JY; Joo HK; Kim HS; Lee SK; Lee KH; Cho CH; Park JB; Jeon BH
    Biochem Biophys Res Commun; 2008 Mar; 368(1):68-73. PubMed ID: 18206643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors.
    Grillo C; D'Ambrosio C; Scaloni A; Maceroni M; Merluzzi S; Turano C; Altieri F
    Free Radic Biol Med; 2006 Oct; 41(7):1113-23. PubMed ID: 16962936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells.
    Kim CS; Son SJ; Kim EK; Kim SN; Yoo DG; Kim HS; Ryoo SW; Lee SD; Irani K; Jeon BH
    Cardiovasc Res; 2006 Feb; 69(2):520-6. PubMed ID: 16325162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOE1 interacts with p53 to modulate its transactivation potential.
    Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
    FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APE/Ref-1 is controlled by both redox and cAMP-dependent mechanisms in rat thyroid cells.
    Tell G; Pines A; Pandolfi M; D'Elia AV; Donnini D; Lonigro R; Manzini G; Russo D; Di Loreto C; Damante G
    Horm Metab Res; 2002 Jun; 34(6):303-10. PubMed ID: 12173070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of redox/repair protein Ref-1 as a potent activator of p53.
    Jayaraman L; Murthy KG; Zhu C; Curran T; Xanthoudakis S; Prives C
    Genes Dev; 1997 Mar; 11(5):558-70. PubMed ID: 9119221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells.
    Chen D; Yu Z; Zhu Z; Lopez CD
    Cancer Res; 2006 Apr; 66(7):3485-94. PubMed ID: 16585172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation by p53: one protein, many possibilities.
    Laptenko O; Prives C
    Cell Death Differ; 2006 Jun; 13(6):951-61. PubMed ID: 16575405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.